Pfizer’s RSV vaccine

Facts for Prelims (FFP)   Source: livescience  Context: The Food and Drug Administration (FDA) has granted approval to Pfizer’s vaccine, Abrysvo, aimed at safeguarding new-borns from respiratory syncytial virus (RSV) by vaccinating pregnant individuals during the latter stages of pregnancy. Abrysvo has been authorized for use in adults aged 60 and above to protect them …